Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas? (Q47196603)

11 January 2018

title

Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas? (English)

1 reference

11 January 2018

Mucin 16, cell surface associated

main subject

1 reference

based on heuristic

inferred from title

author

Athanasios Dimopoulos

9

1 reference

11 January 2018

author name string

Nikolaos Thomakos

1

1 reference

11 January 2018

Alexandros Rodolakis

2

1 reference

11 January 2018

Flora Zagouri

3

1 reference

11 January 2018

Dimitrios Zacharakis

4

1 reference

11 January 2018

Maria Sotiropoulou

5

1 reference

11 January 2018

Nikolaos Akrivos

6

1 reference

11 January 2018

Dimitrios Haidopoulos

7

1 reference

11 January 2018

Christos A Papadimitriou

8

1 reference

11 January 2018

Aris Antsaklis

10

1 reference

11 January 2018

publication date

1 September 2012

1 reference

11 January 2018

Archives of Gynecology and Obstetrics

published in

1 reference

11 January 2018

volume

287

1 reference

11 January 2018

issue

1

1 reference

11 January 2018

page(s)

97-102

1 reference

11 January 2018

https://scigraph.springernature.com/pub.10.1007/s00404-012-2529-6

exact match

0 references

cites work

Treatment of early uterine sarcomas: disentangling adjuvant modalities

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Prognostic features of surgical stage I uterine carcinosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Management of malignant, mixed mesodermal tumors of the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Uterine carcinosarcoma is derived from a single stem cell: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Preoperative CA 125 in endometrial cancer: is it useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2529-6

10.1007/S00404-012-2529-6

21 January 2018

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

22941327

1 reference

11 January 2018